Susquehanna International Group, LLP Theravance Biopharma, Inc. Transaction History

Susquehanna International Group, LLP

$568 Billion
Q1 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$8.58 - $11.4 $115,718 - $153,751	13,487 Added 33.91%	53,263 $598,000
Q3 2023 Nov 14, 2023	BUY	$8.38 - $10.44 $6,251 - $7,788	746 Added 1.91%	39,776 $343,000
Q2 2023 Aug 11, 2023	SELL	$10.16 - $11.92 $124,785 - $146,401	-12,282 Reduced 23.94%	39,030 $403,000
Q1 2023 May 16, 2023	SELL	$9.87 - $11.44 $1.21 Million - $1.41 Million	-122,906 Reduced 70.55%	51,312 $556,000
Q4 2022 Feb 14, 2023	BUY	$9.65 - $11.34 $758,837 - $891,732	78,636 Added 82.27%	174,218 $1.95 Million

Q3 2022 Nov 14, 2022	BUY	$8.39 - $10.22 $525,750 - $640,426	62,664 Added 190.36%	95,582 $969,000
Q2 2022 Aug 15, 2022	SELL	$8.41 - $10.34 $275,520 - $338,748	-32,761 Reduced 49.88%	32,918 $298,000
Q1 2022 May 16, 2022	SELL	$8.33 - $12.96 $1.52 Million - $2.37 Million	-182,782 Reduced 73.57%	65,679 $628,000
Q4 2021 Feb 14, 2022	BUY	$7.42 - $11.05 $407,669 - $607,109	54,942 Added 28.39%	248,461 $2.75 Million
Q3 2021 Nov 15, 2021	BUY	$6.77 - $14.41 $1.24 Million - $2.63 Million	182,438 Added 1646.4%	193,519 $1.43 Million
Q4 2020 Feb 16, 2021	SELL	$14.89 - $20.16 $372,622 - $504,504	-25,025 Reduced 69.31%	11,081 $197,000
Q3 2020 Nov 16, 2020	BUY	$14.79 - $22.49 $139,307 - $211,833	9,419 Added 35.29%	36,106 $534,000
Q2 2020 Aug 14, 2020	BUY	$20.64 - $30.69 $199,898 - $297,232	9,685 Added 56.96%	26,687 $560,000
Q1 2020 May 15, 2020	BUY	$17.84 - $31.21 $303,315 - $530,632	17,002 New	17,002 $393,000
Q4 2019 Feb 14, 2020	SELL	$16.12 - $25.89 $597,487 - $959,612	-37,065 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$16.51 - $23.78 $18,474 - $26,609	1,119 Added 3.11%	37,065 $722,000
Q2 2019 Aug 16, 2019	BUY	$15.6 - $25.15 $53,554 - $86,339	3,433 Added 10.56%	35,946 $587,000
Q2 2019 Aug 14, 2019	BUY	$15.6 - $25.15 $360,188 - $580,688	23,089 Added 245.0%	32,513 $531,000
Q4 2018 Feb 14, 2019	BUY	$22.52 - $35.07 $212,228 - $330,499	9,424 New	9,424 $241,000
Q1 2018 May 15, 2018	SELL	$23.37 - $29.71 $709,489 - $901,965	-30,359 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$25.82 - $35.66 $783,869 - $1.08 Million	30,359	30,359 $846,000

Others Institutions Holding TBPH

# of Institutions

124

Shares Held

49.6M

Call Options Held

1.4K

Put Options Held

2.3K

Weiss Asset Management LP Boston, MA

7.46M
Shares

$62 Million
2.91% of portfolio
Madison Avenue Partners, LP New York, NY

7.01M
Shares

$58.3 Million
12.55% of portfolio
Seth Klarman Baupost Group LLC | Boston, Ma

6.59M
Shares

$54.9 Million
1.62% of portfolio
Black Rock Inc. New York, NY

4.21M
Shares

$35 Million
0.0% of portfolio
Irenic Capital Management LP New York, NY

2.76M
Shares

$23 Million
5.05% of portfolio

View Full List

About Theravance Biopharma, Inc.

Ticker TBPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,782,400
Market Cap $556M
Description
Theravance Biopharma, Inc., a biopharmaceutical company, discovers, develops, and commercializes respiratory medicines in the United States, Europe, and Asia. The company offers YUPELRI, a once-daily, nebulized long-acting muscarinic antagonist used for the treatment of chronic obstructive pulmonary disease (COPD). Its product portfolio also inc...

More about TBPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account